Keyphrases
Methotrexate
100%
Thiotepa
100%
Previously Untreated
100%
Neoplastic Meningitis
100%
Intraventricular
100%
Systemic Disease
40%
Intrathecal Methotrexate
40%
Breast Cancer
20%
Chemotherapy
20%
Early Treatment
20%
Response Rate
20%
Lung
20%
Breast
20%
Malignancy
20%
Group Studies
20%
Prospective Randomized Trial
20%
Neurologic Deficit
20%
Median Survival
20%
Performance Status
20%
Mucositis
20%
Early Diagnosis
20%
Mass Lesion
20%
Well-balancing
20%
Prognostic Factors
20%
Twice Daily
20%
Lymphatics
20%
New Therapeutic Approaches
20%
Neurological Improvement
20%
Primary Cancer
20%
Systemic Therapy
20%
Cooperative Group
20%
Neurologic Complications
20%
Cranial Nerve Palsy
20%
Poor Performance Status
20%
Systemic Cancer
20%
Non-ambulatory
20%
CSF Cytology
20%
Pharmacology, Toxicology and Pharmaceutical Science
Meningitis
100%
Thiotepa
100%
Methotrexate
100%
Intrathecal
28%
Systemic Disease
28%
Breast Cancer
14%
Primary Tumor
14%
Malignant Neoplasm
14%
Chemotherapy
14%
Mucosa Inflammation
14%
Neurological Complication
14%
Cranial Nerve Paralysis
14%
Nursing and Health Professions
Meningitis
100%
Methotrexate
100%
Thiotepa
100%
Systemic Disease
28%
Breast Cancer
14%
Malignant Neoplasm
14%
Early Diagnosis
14%
Primary Tumor
14%
Systemic Therapy
14%
Neurological Complication
14%
Mucosa Inflammation
14%
Cranial Nerve Paralysis
14%
Cerebrospinal Fluid Cytology
14%
Neuroscience
Meningitis
100%
Methotrexate
100%
Intrathecal
28%
Cranial Nerve
14%